Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.14670/HH-18-693
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Zhong, Bi-xi | - |
dc.contributor.author | Shen, Fu-ming | - |
dc.contributor.author | Chen, Ji-kuai | - |
dc.date.accessioned | 2024-06-07T11:15:57Z | - |
dc.date.available | 2024-06-07T11:15:57Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | Histology and Histopathology Vol. 39, nº7 (2024) | es |
dc.identifier.issn | 0213-3911 | - |
dc.identifier.issn | 1699-5848 | - |
dc.identifier.uri | http://hdl.handle.net/10201/142168 | - |
dc.description.abstract | Heat shock proteins (HSPs) are a family of proteins involved in protein folding and maturation that are expressed by cells in response to stressors including heat shock. Recent studies have demonstrated that HSPs play major roles in carcinogenesis by regulating angiogenesis, cell proliferation, migration, invasion, metastasis, apoptosis, as well as therapy resistance to certain anticancer drugs. Despite being the largest and most diverse subgroup of the HSP family, HSP40 (DNAJ) is an understudied family of co-chaperones. HSP40 family members are also known to be involved in various types of cancers. In this article, we review the involvement of human HSP40 family members in various aspects of cancer biology. In addition, we highlight the possible potential of HSP40 as a tumor biomarker or drug target for improving the prognosis and treatment of cancer patients in the future | es |
dc.format | application/pdf | es |
dc.format.extent | 7 | es |
dc.language | eng | es |
dc.publisher | Universidad de Murcia, Departamento de Biologia Celular e Histiologia | es |
dc.relation | Sin financiación externa a la Universidad | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | HSP40 | es |
dc.subject | Cancer | es |
dc.subject | Diagnostic biomarker | es |
dc.subject | Molecular chaperone protein | es |
dc.subject | Prognosis | es |
dc.subject | Target therapy | es |
dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología | es |
dc.title | The role of HSP40 in cancer: Recent advances | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | https://doi.org/10.14670/HH-18-693 | - |
Aparece en las colecciones: | Vol.39, nº7 (2024) |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Zhong-39-845-851-2024.pdf | 389,81 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons